Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ahn

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Genes and Immunity|December 19, 2014
Meta-analysis of the TNFAIP3 region in psoriasis reveals a risk haplotype that is distinct from other autoimmune diseasesJ Nititham, K E Taylor, R Gupta, et al.
JCO Precision Oncology|October 31, 2022
Pertuzumab Plus Trastuzumab in Patients With Colorectal Cancer With <i>ERBB2</i> Amplification or <i>ERBB2/3</i> Mutations: Results From the TAPUR StudyRanju Gupta, Funda Meric-Bernstam, Michael Rothe, et al.
Brain Imaging and Behavior|July 10, 2013
The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancerK L Pomykala, P A Ganz, J E Bower, et al.
Pediatric Obesity|June 14, 2013
Gender difference in interactions between MAOA promoter uVNTR polymorphism and negative familial stressors on body mass index among Chinese adolescentsB Xie, D Li, S J London, et al.
Oncogene|June 1, 2011
Cancer cells promote survival through depletion of the von Hippel-Lindau tumor suppressor by protein crosslinkingD-S Kim, Y-B Choi, B-G Han, et al.
Targeted Oncology|October 17, 2020
Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyTareq Al Baghdadi, Elizabeth Garrett-Mayer, Susan Halabi, et al.
Journal of Cellular Physiology|May 5, 2017
Folic acid is necessary for proliferation and differentiation of C2C12 myoblastsSeong Y Hwang, Yong J Kang, Bokyung Sung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2020
Corrigendum to 'Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)': Annals of Oncology, Volume 31, Issue 1, 2020, Pages 79-87M Kundranda, A C Gracian, S F Zafar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)M Kundranda, A C Gracian, S F Zafar, et al.
JCO Precision Oncology|February 1, 2022
Palbociclib in Patients With Pancreatic and Biliary Cancer With <i>CDKN2A</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry StudyTareq Al Baghdadi, Susan Halabi, Elizabeth Garrett-Mayer, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Genes and Immunity|December 19, 2014
Meta-analysis of the TNFAIP3 region in psoriasis reveals a risk haplotype that is distinct from other autoimmune diseasesJ Nititham, K E Taylor, R Gupta, et al.
JCO Precision Oncology|October 31, 2022
Pertuzumab Plus Trastuzumab in Patients With Colorectal Cancer With <i>ERBB2</i> Amplification or <i>ERBB2/3</i> Mutations: Results From the TAPUR StudyRanju Gupta, Funda Meric-Bernstam, Michael Rothe, et al.
Brain Imaging and Behavior|July 10, 2013
The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancerK L Pomykala, P A Ganz, J E Bower, et al.
Pediatric Obesity|June 14, 2013
Gender difference in interactions between MAOA promoter uVNTR polymorphism and negative familial stressors on body mass index among Chinese adolescentsB Xie, D Li, S J London, et al.
Oncogene|June 1, 2011
Cancer cells promote survival through depletion of the von Hippel-Lindau tumor suppressor by protein crosslinkingD-S Kim, Y-B Choi, B-G Han, et al.
Targeted Oncology|October 17, 2020
Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyTareq Al Baghdadi, Elizabeth Garrett-Mayer, Susan Halabi, et al.
Journal of Cellular Physiology|May 5, 2017
Folic acid is necessary for proliferation and differentiation of C2C12 myoblastsSeong Y Hwang, Yong J Kang, Bokyung Sung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2020
Corrigendum to 'Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)': Annals of Oncology, Volume 31, Issue 1, 2020, Pages 79-87M Kundranda, A C Gracian, S F Zafar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)M Kundranda, A C Gracian, S F Zafar, et al.
JCO Precision Oncology|February 1, 2022
Palbociclib in Patients With Pancreatic and Biliary Cancer With <i>CDKN2A</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry StudyTareq Al Baghdadi, Susan Halabi, Elizabeth Garrett-Mayer, et al.
Pageof 9